These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22614626)

  • 1. Management of mineral and bone disorder after kidney transplantation.
    Kalantar-Zadeh K; Molnar MZ; Kovesdy CP; Mucsi I; Bunnapradist S
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):389-403. PubMed ID: 22614626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Disease after Kidney Transplantation.
    Bouquegneau A; Salam S; Delanaye P; Eastell R; Khwaja A
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1282-1296. PubMed ID: 26912549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic bone disease after renal transplantation.
    Haffner D; Schüler U
    Curr Opin Pediatr; 2014 Apr; 26(2):198-206. PubMed ID: 24535492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney and bone update : the 5-year history and future of CKD-MBD. Mineral and bone disorder in kidney transplant recipients].
    Fujii N; Okuno A; Yonemoto S; Nishimura K; Kishikawa H; Ichikawa Y
    Clin Calcium; 2012 Jul; 22(7):1050-8. PubMed ID: 22750938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Mineral Disease After Kidney Transplantation.
    Torregrosa JV; Ferreira AC; Cucchiari D; Ferreira A
    Calcif Tissue Int; 2021 Apr; 108(4):551-560. PubMed ID: 33765230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in bone and mineral metabolism in kidney transplant patients with chronic kidney disease].
    López Oliva MO; Del Castillo Caba D; Sánchez Plumed J
    Nefrologia; 2009; 29 Suppl 1():31-7. PubMed ID: 19675659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineral and Bone Disease in Kidney Transplant Recipients.
    Altman AM; Sprague SM
    Curr Osteoporos Rep; 2018 Dec; 16(6):703-711. PubMed ID: 30390201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Bone Histomorphometry after Kidney Transplantation.
    Keronen S; Martola L; Finne P; Burton IS; Kröger H; Honkanen E
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):894-903. PubMed ID: 31088851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
    Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.
    Evenepoel P; Behets GJ; Viaene L; D'Haese PC
    Kidney Int; 2017 Feb; 91(2):469-476. PubMed ID: 27998642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of kidney transplantation on bone.
    Kodras K; Haas M
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():63-75. PubMed ID: 16884399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKD-mineral and bone disorder management in kidney transplant recipients.
    Alshayeb HM; Josephson MA; Sprague SM
    Am J Kidney Dis; 2013 Feb; 61(2):310-25. PubMed ID: 23102732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.
    Evenepoel P; Claes K; Meijers B; Laurent MR; Bammens B; Naesens M; Sprangers B; Cavalier E; Kuypers D
    Nephrol Dial Transplant; 2020 Apr; 35(4):697-705. PubMed ID: 30339234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality.
    Block GA
    Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):376-81. PubMed ID: 21519253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive agents and bone disease in renal transplant patients with hypercalcemia.
    Sessa A; Esposito A; Iavicoli GD; Lettieri E; Dente G; Costa C; Bergallo M; Rossano R; Capuano M
    Transplant Proc; 2010 May; 42(4):1148-55. PubMed ID: 20534247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M; Miller PD
    Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?
    Blaslov K; Katalinic L; Kes P; Spasovski G; Smalcelj R; Basic-Jukic N
    Int Urol Nephrol; 2014 May; 46(5):1019-24. PubMed ID: 24217803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with calcimimetics in kidney transplantation.
    Morales E; Gutierrez E; Andres A
    Transplant Rev (Orlando); 2010 Apr; 24(2):79-88. PubMed ID: 20303456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone biomarkers in de novo renal transplant recipients.
    Evenepoel P; Cavalier E; D'Haese PC
    Clin Chim Acta; 2020 Feb; 501():179-185. PubMed ID: 31734147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.